Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cyclacel Pharmaceuticals Inc CYCCP


Primary Symbol: CYCC

Healthcare Biotechnology
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin-dependent kinase 9 (CDK9) inhibitor, in solid tumors and hematological malignancies. The epigenetic/anti-mitotic... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CYCC)

Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds

GlobeNewswire 8 days ago

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds

GlobeNewswire 9 days ago

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

GlobeNewswire 10 days ago

Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule

GlobeNewswire October 24, 2024

Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

GlobeNewswire October 23, 2024

Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

GlobeNewswire October 9, 2024

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study

GlobeNewswire September 25, 2024

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire September 4, 2024

Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter

GlobeNewswire September 3, 2024
View More News ››

Opinion & Analysis (NDAQ:CYCC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CYCC)

Cyclacel Pharmaceuticals (CYCC): A Promising Oncology Biotec

http://beyondspx.com/2024/08/01/cyclacel-pharmaceuticals-cycc-a-promising-oncology-biotech-with-exciting-pipeline-developments/
MikeTester - August 2, 2024

Cyclacel Pharmaceuticals to Release First Quarter 2024 Finan

News; $CYCCP Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial ResultsBERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE...
whytestocks - May 8, 2024

CYCC.....FOMO's wanted....sign up to the Chasers list

JMHO
Iseneschal - April 25, 2024

CYCC.....zero volume at the low

No the bottom feeders are offing their paper
Iseneschal - April 25, 2024

CYCC....N.L.O.D $1.41

Yesterdays vol & price action was just a Pump & Dump by none other than the Infamous Mr. Maggot !!!!!
Iseneschal - April 25, 2024

CYCC....N.L.O.D.....$1.59

Ya have to be ready for these RS thinners throwing everyone a "curveball" Market Makers are throwing a few of these lately
Iseneschal - April 25, 2024
View more Bullboard ››

Star Diamond Corp

Star Diamond Corp

Star Diamond Corporation is a Canada-based company engaged in the acquisition, exploration and development of mineral ...
View More »